The role of CDK and PI3K/mTOR inhibitors

Date 06 November 2015
Event ESO Advanced Breast Cancer Third International Consensus Conference
Session Revolutionizing ER+ ABC management
Topics Breast Cancer, Metastatic
Cytotoxic agents
Translational Research
Presenter F. André, FR